Total amount: € 0,00
Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246
Online ISSN 1827-160X
Evangelisti M., Vitiello E., Campi M. G., Magnano A. C., Ruzzon T.
Istituto Nazionale per la Ricerca sul Cancro, Servizio Biotecnologie, Genova, Italy
Biotechnology, representing the most promising innovative technology for the future, is able to contribute to improving the quality of life. Even though it can be applied in numerous different sectors, it has particular importance in the biomedical field. In this report, we shall look at the way in which biotechnology is able to contribute to the field of oncology, in particular, for diagnostic and therapy purposes. In addition, biotechnology brings about benefits in other sectors too, like those of agriculture-food, environmental protection and chemicals, etc. We shall present a panoramic view on the development of biotechnology in the main industrialized European countries whilst referring to other countries in the world which lead in this area, focusing especially on the United States. We shall examine, in particular, the biotechnology development in the United Kingdom, Germany and France, the three most competitive countries in Europe; we shall also consider the situation of biotechnology in Italy, a country where, despite having to still make progress in the field, has achieved some very important results in the past few years. Moreover, the essential factors which are able to favour the development of biotechnology, which is considered by now irreversible, shall be looked into. These factors principally regard a sound and enduring co-operation between the research world and industries, whose interaction with one another is extremely vital in order to overcome the existing limits and uncertainties, also within the area of carrying out technology transfer. In addition, it is important to remember the fundamental need for appropriate legislative policies which can render biotechnology development simpler, whilst taking into account the common European regulations, not to mention the economic incentives and tax aids for those who intend on involving themselves within in the biotechnology sector. It is most important to not underestimate the public opinion on biotechnology which is often one of suspicion and mistrust, greatly influenced by the thinking that there can be more health risks associated with biotechnology than actual benefits. However, we must also remember that the biotechnology field is a relatively recent scientific discipline, and so little is known by the public at large and it is sometimes true that, unfortunately, the mass-media actually contributes negatively to spreading the mistrust and ambiguity which can surround it, often providing incorrect, misleading and unreliable sources of information.